PRESS RELEASE published on 06/09/2026 at 14:49, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses a 4.74% stake in Tate & Lyle plc as of 09-Jun-2026. Form 8.3 filed under Rule 8.3 of the Takeover Code Form 8.3 The Vanguard Group Takeover Code Stake Disclosure Tate & Lyle Plc
PRESS RELEASE published on 06/09/2026 at 14:49, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% stake in Spire Healthcare Group plc through 14,479,362 ordinary shares. Transaction details include a sale of 2,850 shares at 2.17 GBP per unit Vanguard Group Spire Healthcare Stake Disclosure Share Sale Financial Transaction
BRIEF published on 06/09/2026 at 14:48, 3 months 8 days ago The Vanguard Group, Inc.: Disclosure on Beazley plc Position Takeover Code Securities Disclosure Vanguard Group Shareholding Beazley Plc
PRESS RELEASE published on 06/09/2026 at 14:47, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.57% ownership in Schroders plc as of 08 June 2026. Details of relevant securities disclosed in Form 8.3 Form 8.3 Relevant Securities Schroders Plc Vanguard Group Ownership Disclosure
BRIEF published on 06/09/2026 at 14:46, 3 months 8 days ago The Vanguard Group's Position on LondonMetric Property and Schroder Real Estate Takeover Code Securities Disclosure Vanguard Group LondonMetric Property Schroder Real Estate
PRESS RELEASE published on 06/09/2026 at 14:46, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses a 5.05% stake in Picton Property Income Limited as of 08 June 2026. Details on securities, derivatives, and dealings provided Securities The Vanguard Group, Inc. Stake Disclosure Derivatives Picton Property Income Limited
PRESS RELEASE published on 06/09/2026 at 14:46, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 5.05% interest in NCC Group plc's 1p ordinary shares through Form 8.3 filing on 08 June 2026 Form 8.3 Relevant Securities Takeover Code Vanguard Group NCC Group Plc
PRESS RELEASE published on 06/09/2026 at 14:45, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.01% interest in JTC plc through Form 8.3 in accordance with the Takeover Code Form 8.3 Vanguard Group Inc. Takeover Code JTC Plc 5.01% Interest
PRESS RELEASE published on 06/09/2026 at 14:43, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% ownership in Beazley plc through Form 8.3 filing on 09-Jun-2026 Form 8.3 The Vanguard Group Ownership Disclosure Financial Securities Beazley Plc
PRESS RELEASE published on 06/09/2026 at 14:41, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses 5.32% ownership stake in LondonMetric Property plc's relevant securities and 0.93% in Schroder Real Estate Investment Trust Limited, as of 8 June 2026 LondonMetric Property Plc Disclosure Vanguard Group Ownership Stake Schroder Real Estate Investment Trust Limited
Published on 09/18/2026 at 06:30, 1 hour 3 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 6 hours 38 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 7 hours 8 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 9 hours 18 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 07:15, 18 minutes ago Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines
Published on 09/18/2026 at 07:00, 33 minutes ago Sandoz receives regulatory approval for generic semaglutide in Canada, paving way to expand patient access to key GLP-1 medicine
Published on 09/18/2026 at 06:45, 48 minutes ago HUBER+SUHNER presents strategy and growth potential at Capital Market Day 2026
Published on 09/18/2026 at 05:30, 2 hours 3 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/17/2026 at 19:00, 12 hours 32 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 17:40, 13 hours 53 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 13 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
